(Q35360714)

English

Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

hepatorenal syndrome

1 reference

based on heuristic

inferred from title

author name string

Brensing KA

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Textor J

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Perz J

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Schiedermaier P

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Raab P

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Strunk H

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Klehr HU

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Kramer HJ

8

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Spengler U

9

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Schild H

10

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sauerbruch T

11

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

language of work or name

0 references

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

288-295

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Terlipressin may influence the outcome of hepatorenal syndrome complicating alcoholic hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Endothelin and nitric oxide in hepatorenal syndrome: a balance reset.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Cirrhosis: ascites and hepatorenal syndrome. Recent advances in pathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

26 September 2018

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Transjugular intrahepatic portal-systemic shunts: the state of the art.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Hepatorenal disorders: role of the sympathetic nervous system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Hepatorenal syndrome: resolution after transjugular intrahepatic portosystemic shunt.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Risk factors and outcome of 107 patients with decompensated liver disease and acute renal failure (including 26 patients with hepatorenal syndrome): the role of hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

The treatment of portal hypertension: A meta-analytic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Hepatorenal reflex regulating kidney function.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

27 July 2018

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

26 September 2018

Improvement in renal function in hepatorenal syndrome with N-acetylcysteine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

26 September 2018

Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

26 September 2018

Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

26 September 2018

Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

26 September 2018

Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

26 September 2018

Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

26 September 2018

The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727992

26 September 2018

Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome--experience in 300 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hepatorenal syndrome--newer perspectives

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential treatment of hepatorenal syndrome and posthepatic cirrhosis by intrahepatic portosystemic shunt (TIPSS) and liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Transjugular Intrahepatic Portosystemic Stent-Shunt Procedure for Variceal Bleeding

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatorenal Syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endoscopic manometry of esophageal varices: evaluation of a balloon technique compared with direct portal pressure measurement

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy for hepatorenal syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10896924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/GUT.47.2.288

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35360714&oldid=1600201840"